Rheumatoid Arthritis (RA), a chronic systemic inflammatory disease which affects
approximately 1% of the population, is classically characterized by inflammation and …

Objective To determine if the prevalence of diastolic dysfunction is increased in rheumatoid
arthritis (RA) patients. Methods We conducted a time‐and language‐restricted literature …

We investigated the effects of tocilizumab on endothelial glycocalyx, a determinant of
vascular permeability, and myocardial function in rheumatoid arthritis (RA). Eighty RA …

Objectives Patients with rheumatoid arthritis (RA) are at increased risk for cardiovascular
disease (CVD), although strategies to detect subclinical CVD are poorly characterised. The …

Aim Patients with rheumatoid arthritis (RA) have an increased risk of cardiac dysfunction and
heart failure (HF) due to a pro-inflammatory state. Detecting cardiac dysfunction in RA is …

New parameters for identifying subclinical atherosclerosis in patients with primary Sjögren’s
syndrome: a pilot study Page 1 New parameters for identifying subclinical atherosclerosis in …

The increased risk of cardiovascular disease (CVD) associated with rheumatologic
conditions is well recognized and has been described extensively in systemic lupus …

Aims Cardiac contractile dysfunction is prevalent in rheumatoid arthritis (RA), with an
increased risk for heart failure. A hallmark of RA has increased levels of peptidyl arginine …

Chronic inflammation represents the cornerstone of the raised cardiovascular (CV) risk in
patients with inflammatory rheumatic diseases (IRD). Standardized mortality ratios are …

Autoimmune diseases (ADs) encompass multisystem disorders, and cardiovascular
involvement is a well-known feature of autoimmune and inflammatory rheumatic conditions …